LUCD Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Lucid Diagnostics Inc (LUCD) is not a strong buy for a beginner long-term investor at this time. While the stock has some positive catalysts, such as bullish moving averages and an analyst's optimistic price target, the company's weak financial performance, lack of recent significant news, and neutral trading sentiment suggest that this is not an ideal entry point for long-term investment. Additionally, no proprietary trading signals are present to indicate a strong buy opportunity.
The technical indicators show mixed signals. The MACD is below 0 and negatively contracting, indicating bearish momentum. RSI is neutral at 54, suggesting no clear trend. However, the moving averages are bullish (SMA_5 > SMA_20 > SMA_200), and the stock is trading above the pivot level of 1.202, with resistance at 1.267 and support at 1.137.
Bullish moving averages, an analyst's raised price target to $8.25 with a Buy rating, and expected high growth and Medicare coverage in 2026.
Weak financial performance in Q3 2025, including a significant drop in net income (-15.96% YoY), EPS (-60% YoY), and gross margin (-7.31% YoY). No recent news or significant trading trends from insiders or hedge funds.
In Q3 2025, revenue increased by 3.33% YoY to $1,211,000, but net income dropped by 15.96% YoY to -$10,397,000. EPS fell by 60% YoY to -0.1, and gross margin declined by 7.31% YoY to -48.8%. Overall, the company is struggling with profitability and efficiency.
An Ascendiant analyst raised the price target to $8.25 from $8 and maintained a Buy rating, citing expected high growth and Medicare coverage in 2026 as key drivers for the stock's future performance.
